Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dystonia in multiple system atrophy.

S M Boesch1, G K Wenning, G Ransmayr

  • 1Department of Neurology, University Hospital, Innsbruck, Austria.

Journal of Neurology, Neurosurgery, and Psychiatry
|February 28, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional connectivity and topology in patients with restless legs syndrome: a case-control resting-state functional magnetic resonance imaging study.

European journal of neurology·2020
Same author

Signs of early cellular dysfunction in multiple system atrophy.

Neuropathology and applied neurobiology·2020
Same author

Development of neurodegeneration in amyotrophic lateral sclerosis: from up or down?

Journal of neural transmission (Vienna, Austria : 1996)·2020
Same author

Long-term efficacy of opicapone in fluctuating Parkinson's disease patients: a pooled analysis of data from two phase 3 clinical trials and their open-label extensions.

European journal of neurology·2019
Same author

Burden of non-motor symptoms in Parkinson's disease patients predicts improvement in quality of life during treatment with levodopa-carbidopa intestinal gel.

European journal of neurology·2018
Same author

Quality of life improvements in patients with cervical dystonia following treatment with a liquid formulation of abobotulinumtoxinA (Dysport<sup>®</sup> ).

European journal of neurology·2018
Same journal

Cancer risk and mortality in patients with multiple sclerosis in Finland: a retrospective population-based cohort study.

Journal of neurology, neurosurgery, and psychiatry·2026
Same journal

Visuospatial working memory in Huntington's disease: behavioural and structural brain correlates.

Journal of neurology, neurosurgery, and psychiatry·2026
Same journal

Characteristics and outcomes in electric scooter-related traumatic brain injuries in Helsinki.

Journal of neurology, neurosurgery, and psychiatry·2026
Same journal

Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progression.

Journal of neurology, neurosurgery, and psychiatry·2026
Same journal

Durable fluoropolymer drug-eluting stent versus bare-metal stent for the prevention of intracranial in-stent restenosis.

Journal of neurology, neurosurgery, and psychiatry·2026
Same journal

Correction: <i>How well do plasma Alzheimer's disease biomarkers reflect the CSF amyloid status?</i>

Journal of neurology, neurosurgery, and psychiatry·2026
See all related articles

Dystonia is common in untreated Multiple System Atrophy with parkinsonism (MSA-P), often affecting the neck. Levodopa treatment can induce dystonic dyskinesias, primarily in the craniocervical muscles.

Area of Science:

  • Neurology
  • Movement Disorders
  • Neurodegenerative Diseases

Background:

  • Multiple System Atrophy (MSA) is a progressive neurodegenerative disorder.
  • Dystonia is a motor disorder characterized by involuntary muscle contractions.
  • The frequency and characteristics of dystonia in MSA require further elucidation.

Purpose of the Study:

  • To determine the prevalence and clinical presentation of dystonia in patients with Multiple System Atrophy (MSA).
  • To investigate the relationship between dystonia, MSA subtypes (MSA-P and MSA-C), and levodopa treatment.

Main Methods:

  • Prospective follow-up of 24 clinically probable MSA patients over 10 years.
  • Clinical assessment of motor features, including dystonia, at regular intervals.

Related Experiment Videos

  • Evaluation of response to levodopa and development of drug-induced dyskinesias.
  • Confirmatory neuropathological examination in a subset of patients.

    • Main Results:

    • Dystonia was observed in 46% of levodopa-naive MSA patients at initial presentation.
    • Cervical dystonia (antecollis) and unilateral limb dystonia were the most common forms.
    • MSA-P patients showed an initial response to levodopa, unlike MSA-C patients.
    • Levodopa-induced dyskinesias, predominantly craniocervical dystonia, developed in 12 MSA-P patients.

    Conclusions:

    • Dystonia is a frequent manifestation in untreated MSA with parkinsonism (MSA-P).
    • Younger age at onset and putaminal pathology may contribute to dystonia in MSA-P.
    • Levodopa-induced dyskinesias in MSA are predominantly dystonic and affect craniocervical muscles.